Elanco Animal Health Inc (NYSE: ELAN) is -1.48% lower on its value in year-to-date trading and has touched a low of $8.52 and a high of $18.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ELAN stock was last observed hovering at around $14.82 in the last trading session, with the day’s loss setting it -0.14%.
Currently trading at $14.68, the stock is 11.23% and 0.43% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.88 million and changing -0.94% at the moment leaves the stock 0.13% off its SMA200. ELAN registered 26.33% gain for a year compared to 6-month loss of -9.10%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 14.69% gain in the last 1 month and extending the period to 3 months gives it a -13.65%, and is 5.31% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.37% over the week and 4.16% over the month.
Elanco Animal Health Inc (ELAN) has around 9800 employees, a market worth around $7.26B and $4.49B in sales. Fwd P/E is 14.36. Profit margin for the company is -27.94%. Distance from 52-week low is 72.30% and -21.91% from its 52-week high. The company has generated returns on investments over the last 12 months (-11.00%).
The EPS is expected to grow by 3.06% this year.
Elanco Animal Health Inc (ELAN) Top Institutional Holders
549.0 institutions hold shares in Elanco Animal Health Inc (ELAN), with institutional investors hold 99.88% of the company’s shares. The shares outstanding are 492.85M, and float is at 487.63M with Short Float at 2.77%. Institutions hold 99.22% of the Float.
The top institutional shareholder in the company is DODGE & COX with over 83.85 million shares valued at $1.37 billion. The investor’s holdings represent 17.001 of the ELAN Shares outstanding. As of 2024-03-31, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 52.89 million shares valued at $860.97 million to account for 10.7228 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 49.26 million shares representing 9.9875 and valued at over $801.92 million, while BLACKROCK INC. holds 5.4014 of the shares totaling 26.64 million with a market value of $433.7 million.
Elanco Animal Health Inc (ELAN) Insider Activity
The most recent transaction is an insider purchase by Simmons Jeffrey N, the company’s PRESIDENT, CEO AND DIRECTOR. SEC filings show that Simmons Jeffrey N bought 100,000 shares of the company’s common stock on Aug 12 ’24 at a price of $13.01 per share for a total of $1.3 million. Following the purchase, the insider now owns 0.14 million shares.
Elanco Animal Health Inc disclosed in a document filed with the SEC on May 21 ’24 that DOYLE WILLIAM F (Director) bought a total of 15,000 shares of the company’s common stock. The trade occurred on May 21 ’24 and was made at $16.98 per share for $0.25 million. Following the transaction, the insider now directly holds 76330.0 shares of the ELAN stock.
Still, SEC filings show that on Mar 08 ’24, DOYLE WILLIAM F (Director) acquired 15,000 shares at an average price of $16.30 for $0.24 million. The insider now directly holds 61,330 shares of Elanco Animal Health Inc (ELAN).
